SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009096
Filing Date
2023-05-10
Accepted
2023-05-10 16:06:34
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bcel-20230331x10q.htm   iXBRL 10-Q 1757866
2 EX-31.1 bcel-20230331xex31d1.htm EX-31.1 12778
3 EX-31.2 bcel-20230331xex31d2.htm EX-31.2 12362
4 EX-32.1 bcel-20230331xex32d1.htm EX-32.1 8218
  Complete submission text file 0001558370-23-009096.txt   6697888

Data Files

Seq Description Document Type Size
5 EX-101.SCH bcel-20230331.xsd EX-101.SCH 44999
6 EX-101.CAL bcel-20230331_cal.xml EX-101.CAL 46763
7 EX-101.DEF bcel-20230331_def.xml EX-101.DEF 211540
8 EX-101.LAB bcel-20230331_lab.xml EX-101.LAB 360791
9 EX-101.PRE bcel-20230331_pre.xml EX-101.PRE 324472
67 EXTRACTED XBRL INSTANCE DOCUMENT bcel-20230331x10q_htm.xml XML 1086341
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 23906327
SIC: 2834 Pharmaceutical Preparations